CLYM: Climb Bio, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | Fell below 5% | MPM BioImpact LLC | 0.00% | SEC |
Institutional ownership (Q2 2026)
108 institutions reported holding $706.42M of Climb Bio, Inc. on Form 13F (80 the quarter before). 51 opened a new position and 22 sold out. Shares held by institutions: +74%.
| Largest holders | Shares | Value |
|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11,300,939 | $147.36M |
| FMR LLC | 6,790,364 | $88.55M |
| UBS Group AG | 3,404,866 | $44.40M |
| BRAIDWELL LP | 2,797,375 | $36.48M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,506,000 | $32.68M |
| BlackRock, Inc. | 2,354,872 | $30.71M |
| Cormorant Asset Management, LP | 2,106,000 | $27.46M |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 1,939,019 | $25.28M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,698,654 | $22.15M |
| Woodline Partners LP | 1,582,291 | $20.63M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.